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Abstract
Introduction: Merkel cell carcinoma is a rare malignant cutaneous neoplasm that is locally invasive and frequently
metastasizes to lymph nodes, liver, lungs, bone and brain. The incidence of Merkel cell carcinoma has increased in
the past three decades.
Case presentation: A 65-year-old Caucasian man presented with a sudden onset of severe headache and a three-
month history of balance disturbance. Magnetic resonance imaging revealed a large meningeal metastasis. The
radiologic workup showed retroperitoneal and inguinal lymph node metastases. Biopsy of the inguinal lymph
nodes showed metastases of Merkel cell carcinoma. Biopsy from three different suspected skin lesions revealed no
Merkel cell carcinoma, and the primary site of Merkel cell carcinoma remained unknown. Leptomeningeal
metastases, new axillary lymph node metastases, and intraspinal (epidural and intradural) metastases were detected
within six, seven and eight months, respectively, from the start of symptoms despite treating the intracranial
metastasis with gamma knife and the abdominal metastases with surgical dissection and external radiotherapy.
This indicates the aggressive nature of the disease.
Conclusion: To the best of our knowledge, this is the first report in the literature of an intracranial meningeal
metastasis of Merkel cell carcinoma treated with gamma knife and of intraspinal intradural metastases of Merkel
cell carcinoma. Despite good initial response to radiotherapy, recurrence and occurrence of new metastases are
common in Merkel cell carcinoma.
Introduction
Merkel cell carcinoma (MCC) is a rare malignant neo-
plasm of the skin that is locally invasive and frequently
metastasizes to lymph nodes, liver, lungs, bone and
brain [1]. The tumor was first described by Toker in
1972 [2] as a trabecular cell carcinoma. The fact that
MCC is now considered a neuroendocrine tumor is sup-
ported by the presence of calcitonin and neuron-specific
enolase within the tumor [1]. The diagnosis of MCC is
based on the clinical findings of aggressive cutaneous
tumors and the histopathologic examination of speci-
mens using light and electron microscopy with a defined
panel of immunoperoxidase stains [3]. Hodgson [4]
reported that the incidence of MCC has increased
threefold between 1986 and 2001 (the rate of MCC
increased from 0.15 cases per 100,000 in 1986 to 0.44
cases per 100,000 in 2001) [4]. MCC often affects elderly
patients with a mean age at presentation of about
75 years [5]. The head and neck are the most common
sites affected by MCC followed by the legs [6]. A review
of the literature showed a 27% to 60% incidence of local
recurrence, a 45% to 91% incidence of lymph node
metastases and an 18% to 52% incidence of distant
metastases [3].
We report a case of MCC with extensive central ner-
vous system (CNS) metastases with (1) intracranial
meningeal, (2) intraspinal epidural and (3) intraspinal
intradural metastases. A literature review of the reported
cases of the intracranial and the intraspinal spread of
MCC was also performed and presented. * Correspondence: Kasim.Abul-Kasim@med.lu.se
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A 65-year-old Caucasian man presented with a sudden
onset of severe headache and with a three-month his-
tory of balance disturbance. Apart from a pathologic fin-
ger-nose test result and positive Grasset test result on
the left side, no other physical or neurologic abnormal-
ities were found. Computed tomography (CT) showed a
large 4 cm, right-sided parietal parasagittal tumor. Mag-
netic resonance imaging (MRI) showed a large 4 cm,
inhomogeneously enhancing mass that exhibited a wide
falx attachment and dural tail. The meningeal mass was
surrounded by extensive edema of the right parietal lobe
(Figure 1A-C). Cerebral blood volume (CBV) map
showed high intratumoral CBV. MR spectroscopy
showed high choline:N-acetylaspartate and choline:crea-
tine ratios (9.5 and 15, respectively) as well as occur-
rence of lactate and lipid peak in the tumor but not in
the surrounding edema. Although the morphologic find-
ings of the supratentorial mass on conventional MRI
were consistent with meningioma, the occurrence of the
extensive edema and the MR spectroscopy findings were
highly suggestive of metastasis, and our final radiologic
diagnosis was meningeal metastasis. The patient was
admitted to the neurology department, and immediate
treatment with cortisone therapy was started. A search
for the primary tumor with CT and FDG-PET (fluoro-
deoxyglucose positron emission tomography) revealed
lymph node enlargement and increased FDG uptake in
the left inguinal region, iliac, aortocaval and paraaortic
regions. Needle biopsy was obtained from the enlarged
lymph nodes in the left inguinal region. Removal of
three skin lesions in the left lower limb showed no defi-
nite primary tumor.
The large supratentorial meningeal tumor was treated
with gamma knife. MRI control 13 days after treatment
with gamma knife showed marked reduction of the
volume of the intracranial meningeal tumor (Figure 1D).
Retroperitoneal and inguinal lymph node dissection was
performed. Histopathology showed small cell carcinoma
consistent with MCC (immunohistopathologic analysis
was positive for the epithelial markers [AE1/AE3 and
C K 2 0 ]a n dn e u r o f i l a m e n tb u tn e g a t i v ef o rl y m p h o m a
and melanoma markers [CD45 and HMB45, respec-
tively]). Cerebrospinal fluid cytology also showed MCC.
About three months after the retroperitoneal and
inguinal lymph node dissection, the patient received
40 Gy of external radiation for the paraaortal and iliac
retroperitoneal lymph node metastasis and 50.9 Gy for
the metastasis in the left inguinal region. Thereafter,
FDG-PET showed total regression of the FDG uptake in
the lymph nodes, which previously had shown increased
uptake. A planned MRI of the brain about six months
after the onset of symptoms showed evidence of cerebel-
lar leptomeningeal enhancement (Figures 1E and 1F),
which was immediately treated with 30 Gy of palliative
radiation therapy. FDG-PET study approximately seven
months after the onset of symptoms showed a new
enlarged left-sided axillary lymph node with increased
FDG uptake. Approximately eight months after the
onset of symptoms, the patient was admitted for
increasing back pain and a four-day history of rapidly
progressing weakness of the lower limbs that required
the patient to start using a wheelchair. On examination,
lower limb weakness, hyporeflexia and a positive
Babinski sign were found. Emergency MRI of the spine
and the spinal canal showed that the dural sac between
the first and fifth lumbar vertebra was filled with intra-
dural tumor masses with mild contrast enhancement
(Figures 2A to 2F). There were multiple tumor masses
in the epidural space with extension into several lumbar
and lower thoracic neural foramens. Because the
patient’s general condition deteriorated rapidly, further
radiation therapy against the intraspinal tumors was not
possible. The patient died two weeks after the detection
of the intraspinal tumors. At autopsy, lung metastases
were found, but there was no evidence of residual
macroscopic intracranial tumor and no metastases to
the vertebral column. Unfortunately, some technical dif-
ficulties restrained the examination of the spinal canal.
Discussion
This case report initially showed a large supratentorial
meningeal metastasis and later showed cerebellar
Figure 1 Axial magnetic resonance imaging (MRI) scan at three
different occasions. Images (A-C) show the initial MRI with a large
right-sided supratentorial meningeal tumor (arrows) with extensive
surrounding edema (bright signal, C). D) MRI after treatment with
gamma knife shows marked reduction of the tumor size with only
little residual tumor (arrow). E-F) MRI six months from the start of
symptoms shows leptomeningeal metastases with linear contrast
enhancement along the cerebellar sulci (arrows).
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and retroperitoneal metastases were found, but the site
of the patient’s primary MCC remained unknown.
Hitherto, only 18 cases of intracranial metastases of
MCC have been reported, of which 15 cases were
reviewed by Feletti et al. [7]. Table 1 shows the hetero-
geneity of treatment of MCC brain metastases because
there is no evidence-based first choice of treatment
described in the literature for this type of brain metasta-
sis. We believe that until a considerable amount of case
reports are available in the literature, the choice of treat-
ment of MCC brain metastases will depend, as in many
other types of brain metastases, on the number of
metastases, systemic spread of the disease and the acces-
sibility to surgery. We believe that the CNS metastases
of MCC are an expression of a hematogenous systemic
spread of the disease. Barkdull et al. [8] postulated that
an intracranial spread from MCC of the frontal scalp
was through communicating veins rather than local
destructive process. Perineural spread from the head
and neck tumor has also been suggested [9].
This is the first report in the literature of intracranial
metastasis of MCC that was treated with gamma knife,
although the primary indication at the time of gamma
knife surgery was removal of a large meningeal tumor of
unknown origin. The patient and his relatives arranged
the gamma knife treatment at another institution because
the neurosurgeons in our regional institution regarded
the tumor as meningioma with no need for rapid surgical
intervention even though the radiologic report raised the
suspicion of meningeal metastases. Based on the knowl-
edge of the occurrence of lymph node metastases, the
treating oncologists and surgeons aimed to treat the
meningeal tumor with a less invasive method (treatment
w i t hg a m m ak n i f es u r g e r yi n s tead of conventional sur-
gery). In the past few years, the role of gamma knife sur-
gery in the treatment of brain metastasis has proven to
be associated with a longer survival time and better local
tumor control in lung cancer metastases [10] and mela-
noma metastases [11] and in one series has been shown
to provide excellent results in selected patients with one
to 10 brain lesions without prophylactic whole-brain
radiotherapy [12]. Even in our case report, treatment
Figure 2 Magnetic resonance imaging (MRI) scan of the lumbar
spine eight months after the onset of symptoms. T2-weighted
(A) and T1-weighted (B-C) images before and after contrast
administration show mild contrast enhancing multilobular tumors in
the epidural fat behind the dural sac at the level of L3-L4 (black
arrows) and a dural sac filled with intradural tumors (white arrows).
Note the absence of the normal cerebrospinal fluid signal in the
dural sac below the medullary conus. Axial T1-weighted images
before (D) and after (E) contrast administration show the epidural
metastases lateral and dorsal to the dural sac (black arrows in D;
arrowheads in E). The white arrow in E shows the dorsal limit of the
dural sac. F) Axial T1-weighted image after contrast administration
shows a tumor-filled dural sac (white arrows).
Table 1 Compiled from the literature review recently
presented by Feletti et al [7] and a few other reports
Total number of patients reported 18, including our case
report
Age, range 45-71 years
Gender: male/female 12/4 (two not defined)
Location of CNS metastases
Parietal lobe 3
Meningeal 3
Cerebellum 2
Frontal 1
Frontoparietal 1
Hypophysis and cavernous sinus 1
Brainstem 1
Not defined 6
Other metastasis 13 of 18
Lymph nodes 8
Lungs 2
Liver 1
Choroidal 1
Cutaneous 1
Time since the detection of the primary
tumor
0-4 years (50% <1 year)
Treatment for brain metastasis
Radiotherapy + chemotherapy 5
Surgical removal + radiotherapy +
chemotherapy
4
Radiotherapy only 2
Surgical removal only 1
Chemotherapy only 1
Gamma knife 1
Not defined 4
Survival after diagnosis 1 month to >3 years
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good local disease control.
This case report represents the fifth reported case of
MCC metastasis to the spinal canal (Table 2) [13-17].
However, our patient had both epidural and intradural
tumors. To the best of our knowledge, this is the first
case report in the literature on intradural extension of
MCC. The detection of an intradural tumor disqualified
our patient for decompressive laminectomy, which has
previously been proven to be an effective treatment for
spinal and epidural metastasis compared with radiother-
apy or chemotherapy alone [16]. Unlike the other reports
of the intraspinal epidural metastases [13,14], our patient
did not show evidence of osseous vertebral metastases,
which is a usual source of the epidural tumor extension.
The possible explanation for the route of the intradural
metastases is the meningeal spread of the large menin-
geal supratentorial lesion, which gave rise to the cerebel-
lar leptomeningeal metastases detected shortly before the
detection of intradural metastasis. Consistent with other
reports of poor prognosis of intraspinal metastases
[12,13,16], our patient showed evidence of progressive
systemic metastatic spread despite initial improvement
with reduction of tumor size intracranially and regression
of the retroperitoneal lymph nodes.
Conclusion
Our patient with extensive CNS, abdominal and inguinal
metastases showed a good initial response to radiation
therapy. However, evidence of progressive metastatic
spread was demonstrated already six months after the
onset of the patient’s symptoms. This is the first report
in the literature of spinal intradural metastases of MCC,
which further contributed to worsening the patient’s
prognosis because it restrained a debulking and decom-
pressive laminectomy.
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